Progression-Free Survival: Meaningful or Simply Measurable?BOOTH, Christopher M; EISENHAUER, Elizabeth A.Journal of clinical oncology. 2012, Vol 30, Num 10, pp 1030-1033, issn 0732-183X, 4 p.Article

The Imaging Viewpoint: How Imaging Affects Determination of Progression-Free SurvivalSULLIVAN, Daniel Carl; SCHWARTZ, Lawrence H; BINSHENG ZHAO et al.Clinical cancer research (Print). 2013, Vol 19, Num 10, pp 2621-2628, issn 1078-0432, 8 p.Article

Comparison of Power Between Randomized Discontinuation Design and Upfront Randomization Design on Progression-Free SurvivalPINGFU FU; DOWLATI, Afshin; SCHLUCHTER, Mark et al.Journal of clinical oncology. 2009, Vol 27, Num 25, pp 4135-4141, issn 0732-183X, 7 p.Article

Issues in Using Progression-Free Survival When Evaluating Oncology ProductsFLEMING, Thomas R; ROTHMANN, Mark D; LU, Hong Laura et al.Journal of clinical oncology. 2009, Vol 27, Num 17, pp 2874-2880, issn 0732-183X, 7 p.Article

Missing Data and Measurement Variability in Assessing Progression-Free Survival Endpoint in Randomized Clinical TrialsSRIDHARA, Rajeshwari; MANDREKAR, Sumithra J; DODD, Lori E et al.Clinical cancer research (Print). 2013, Vol 19, Num 10, pp 2613-2620, issn 1078-0432, 8 p.Article

Overview: Progression-Free Survival as an Endpoint in Clinical Trials with Solid TumorsKORN, Ronald L; CROWLEY, John J.Clinical cancer research (Print). 2013, Vol 19, Num 10, pp 2607-2612, issn 1078-0432, 6 p.Article

Blinded independent central review of progression in cancer clinical trials: Results from a meta-analysisAMIT, O; MANNINO, F; STONE, A. M et al.European journal of cancer (1990). 2011, Vol 47, Num 12, pp 1772-1778, issn 0959-8049, 7 p.Article

Tumor Burden Modeling Versus Progression-Free Survival for Phase II Decision MakingKAISER, Lee D.Clinical cancer research (Print). 2013, Vol 19, Num 2, pp 314-319, issn 1078-0432, 6 p.Article

Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma: A Randomized Clinical TrialCARVAJAL, Richard D; SOSMAN, Jeffrey A; LAO, Christopher D et al.JAMA, the journal of the American Medical Association. 2014, Vol 311, Num 23, pp 2397-2405, issn 0098-7484, 9 p.Article

Modeling the Relationship between Progression-Free Survival and Overall Survival: The Phase II/III TrialREDMAN, Mary W; GOLDMAN, Bryan H; LEBLANC, Michael et al.Clinical cancer research (Print). 2013, Vol 19, Num 10, pp 2646-2656, issn 1078-0432, 11 p.Article

Poor correlation between progression-free and overall survival in modern clinical trials: Are composite endpoints the answer?AMIR, Eitan; SERUGA, Bostjan; KWONG, Ryan et al.European journal of cancer (1990). 2012, Vol 48, Num 3, pp 385-388, issn 0959-8049, 4 p.Article

Response-adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression-free survival in transplanted patients with multiple myelomaCORSO, Alessandro; GALLI, Monica; CAZZOLA, Mario et al.American journal of hematology. 2012, Vol 87, Num 2, pp 150-154, issn 0361-8609, 5 p.Article

Local Progression After Radiofrequency Ablation for Pulmonary MetastasesVON MEYENFELDT, Erik M; PREVOO, Warner; PEYROT, David et al.Cancer. 2011, Vol 117, Num 16, pp 3781-3787, issn 0008-543X, 7 p.Article

Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndromeZHUANG ZUO; CALIN, George A; DE PAULA, Henrique M et al.Blood. 2011, Vol 118, Num 2, pp 413-415, issn 0006-4971, 3 p.Article

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patientsGAY, Francesca; LAROCCA, Alessandra; PETRUCCI, Maria T et al.Blood. 2011, Vol 117, Num 11, pp 3025-3031, issn 0006-4971, 7 p.Article

Residual Serum Monoclonal Protein Predicts Progression-Free Survival in Patients With Previously Untreated Multiple MyelomaSCHAEFER, Eric W; KUMAR, Shaji; DISPENZIERI, Angela et al.Cancer. 2010, Vol 116, Num 3, pp 640-646, issn 0008-543X, 7 p.Article

Clinical benefit of early phase clinical trial participation for advanced sarcoma patientsJONES, Robin L; OLMOS, David; THWAY, Khin et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 2, pp 423-429, issn 0344-5704, 7 p.Article

Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trialsTANG, P. A; POND, G. R; CHEN, E. X et al.Annals of oncology. 2010, Vol 21, Num 1, pp 19-26, issn 0923-7534, 8 p.Article

Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor PresentationSALAS, Sébastien; DUFRESNE, Armelle; OBERLIN, Odile et al.Journal of clinical oncology. 2011, Vol 29, Num 26, pp 3553-3558, issn 0732-183X, 6 p.Article

Actualités 2010 dans la chirurgie des cancers de l'ovaireCLASSE, Jean-Marc.Oncologie (Paris). 2011, Vol 13, Num 3, issn 1292-3818, S7-S10, SUP1Article

Detecting an Overall Survival Benefit that Is Derived From Progression-Free SurvivalBROGLIO, Kristine R; BERRY, Donald A.Journal of the National Cancer Institute. 2009, Vol 101, Num 23, pp 1642-1649, issn 0027-8874, 8 p.Article

Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinomaJIUWEI CUI; NANYA WANG; HENGJUN ZHAO et al.International journal of cancer (Print). 2014, Vol 134, Num 2, pp 342-351, issn 0020-7136, 10 p.Article

Progression-Free Survival as a Surrogate Endpoint of Overall Survival in Patients With Metastatic Renal Cell CarcinomaHALABI, Susan; RINI, Brian; ESCUDIER, Bernard et al.Cancer. 2014, Vol 120, Num 1, pp 52-60, issn 0008-543X, 9 p.Article

Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphomaKUMAGAI, Shogo; TASHIMA, Masaharu; ARIMA, Nobuyoshi et al.International journal of hematology. 2014, Vol 99, Num 6, pp 737-742, issn 0925-5710, 6 p.Article

Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric CancerTrials: A Meta-AnalysisPAOLETTI, Xavier; OBA, Koji; MORITA, Satoshi et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 21, pp 1667-1670, issn 0027-8874, 4 p.Article